Exposure via partner
(UMLS:C3203559)
- UMLS ID:
- C3203559
- MeSH ID:
- N/A
Synonym(s)
1.
Exposure via partner
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fingolimod Hydrochloride | FAERS: 26 | US FAERS | |
| 2 | Testosterone | FAERS: 23 | US FAERS | |
| 3 | Imatinib Mesylate | FAERS: 19 | US FAERS | |
| 4 | Sildenafil Citrate | FAERS: 16 | US FAERS | |
| 5 | Estradiol | FAERS: 9 | US FAERS | |
| 6 | Estrogens, Conjugated (USP) | FAERS: 9 | US FAERS | |
| 7 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 6 | US FAERS | |
| 8 | NuvaRing | FAERS: 5 | US FAERS | |
| 9 | Finasteride | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Isotretinoin | FAERS: 4 | US FAERS | |
| 11 | Pregabalin | FAERS: 4 | US FAERS | |
| 12 | Dasatinib | FAERS: 3 | US FAERS | |
| 13 | Fluoxetine | FAERS: 3 | US FAERS | |
| 14 | PCI 32765 | FAERS: 3 | US FAERS | |
| 15 | teriflunomide | FAERS: 3 | US FAERS | |
| 16 | Alprostadil | FAERS: 2 | US FAERS | |
| 17 | Aripiprazole | FAERS: 2 | US FAERS | |
| 18 | Atorvastatin | FAERS: 2 | US FAERS | |
| 19 | Everolimus | FAERS: 2 | US FAERS | |
| 20 | Fentanyl | FAERS: 2 | US FAERS | |
| 21 | Lenalidomide | FAERS: 2 | US FAERS | |
| 22 | Ribavirin | FAERS: 2 | US FAERS | |
| 23 | Varenicline | FAERS: 2 | US FAERS | |
| 24 | eltrombopag | FAERS: 2 | US FAERS | |
| 25 | tofacitinib | FAERS: 2 | US FAERS | |
| 26 | Abiraterone Acetate | FAERS: 1 | US FAERS | |
| 27 | Atorvastatin | FAERS: 1 | US FAERS | |
| 28 | Azathioprine | FAERS: 1 | US FAERS | |
| 29 | Canagliflozin | FAERS: 1 | US FAERS | |
| 30 | Capecitabine | FAERS: 1 | US FAERS | |
| 31 | Citalopram | FAERS: 1 | US FAERS | |
| 32 | Crizotinib | FAERS: 1 | US FAERS | |
| 33 | Dehydroepiandrosterone | FAERS: 1 | US FAERS | |
| 34 | Gabapentin | FAERS: 1 | US FAERS | |
| 35 | Ganciclovir | FAERS: 1 | US FAERS | |
| 36 | LCZ 696 | FAERS: 1 | US FAERS | |
| 37 | Leflunomide | FAERS: 1 | US FAERS | |
| 38 | Lidoderm | FAERS: 1 | US FAERS | |
| 39 | MDV 3100 | FAERS: 1 | US FAERS | |
| 40 | Methylprednisolone | FAERS: 1 | US FAERS | |
| 41 | Miconazole | FAERS: 1 | US FAERS | |
| 42 | Octreotide | FAERS: 1 | US FAERS | |
| 43 | Ospemifene | FAERS: 1 | US FAERS | |
| 44 | Sertraline | FAERS: 1 | US FAERS | |
| 45 | Sulfasalazine | FAERS: 1 | US FAERS | |
| 46 | Sunitinib | FAERS: 1 | US FAERS | |
| 47 | Sunitinib | FAERS: 1 | US FAERS | |
| 48 | Triumeq | FAERS: 1 | US FAERS | |
| 49 | Valsartan | FAERS: 1 | US FAERS | |
| 50 | Vardenafil Dihydrochloride | FAERS: 1 | US FAERS | |
| 51 | Vardenafil hydrochloride trihydrate | FAERS: 1 | US FAERS | |
| 52 | bosutinib | FAERS: 1 | US FAERS | |
| 53 | clindamycin phosphate | FAERS: 1 | US FAERS | |
| 54 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 55 | pazopanib | FAERS: 1 | US FAERS | |
| 56 | regorafenib | FAERS: 1 | US FAERS | |
| 57 | Octreotide | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.